In papillary thyroid carcinoma, genetic alterations such as RET/TRK rearrangements or BRAF and RAS mutations usually lead to signaling derangements in the mitogen-activated protein kinase pathway. The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.